A Dark Vector Cognition product

Item 4. Controls and Procedures

2K characters. Original on sec.gov ·

Item 4. Controls and Procedures

We performed an evaluation of the effectiveness of our disclosure controls and procedures as of July 1, 2023. The evaluation was performed with the participation of senior management of each business segment and key Corporate functions, under the supervision of our Chairman, President and Chief Executive Officer (CEO) and our Executive Vice President and Chief Financial Officer (CFO). Based on this evaluation, the CEO and CFO concluded that our disclosure controls and procedures were operating and effective as of July 1, 2023.

There were no changes in our internal control over financial reporting during the fiscal quarter ended July 1, 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following provides information about our second quarter of 2023 repurchases of equity securities that are registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended:

Period (shares in thousands)**Total Number of Shares Purchased ***Average Price Paid per Share (excluding commissions)**Total Number of Shares Purchased as part of Publicly Announced Plan ***Maximum Number of Shares that may yet be Purchased under the Plan
April 2, 2023 – May 6, 2023875$67.848755,820
May 7, 2023 – June 3, 20232,27564.042,2753,545
June 4, 2023 – July 1, 20231,03565.241,0352,510
Total4,185$65.134,185

** These shares were purchased pursuant to a share repurchase program to repurchase up to 25 million shares of Textron common stock that was authorized on January 25,2022, which had no expiration date.*

On July 24, 2023, Textron's Board of Directors approved a new authorization for the repurchase of up to 35 million shares of our common stock. This share repurchase program has no expiration date and replaced the prior share repurchase authorization that had 2.3 million remaining shares available for repurchase.

Item 5. Other Information

Previous: Item 3. Quantitative and Qualitative Disclosures About Market Risk · Next: Item 5. 07 Submission of Matters to a Vote of Security Holders.